Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-25 @ 9:48 PM
Study NCT ID:
NCT02540460
Status:
COMPLETED
Last Update Posted:
2015-09-04
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371
Sponsor:
LigaChem Biosciences, Inc.
Organization:
Study Overview
Official Title:
A Phase I Clinical Study, Multiple Dose of LCB01-0371 in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2015-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the population pharmacokinetics of LCB01-0371 after a multiple oral dose in healthy male subjects.
To investigate safety, tolerability of LCB01-0371 after a multiple oral dose in healthy male subjects.
To investigate safety, tolerability of LCB01-0371 after a multiple oral dose in healthy male subjects.
Detailed Description:
Double blind, randomized, placebo control, multiple dose, dose escalation study
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: